First Progression of MGMT Promoter-methylated Glioblastoma
1 clinical trials · Condition
◉ Watch First Progression of MGMT Promoter-methylated Glioblastoma
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of Romiplostim for Thrombocytopenia Induced by Lomustine at First Progression of MGMT Promoter-meth Glioblastoma (NCT04933942) | European Organisation for Research and Treatment of Cancer - EORTC | 2022-09-13 |
Track First Progression of MGMT Promoter-methylated Glioblastoma automatically
Every clearance here is in the API, with alerts when new ones post.